Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy
1996

Prognostic Factors in Small-Cell Lung Cancer and Quality of Life During Chemotherapy

Sample size: 406 publication Evidence: moderate

Author Information

Author(s): J Bernhard, C Hürny, M Bacchi, RA Joss, F Cavalli, H-J Senn, S Leyvraz, R Stahel, C Ludwig, P Alberto

Primary Institution: Swiss Group for Clinical Cancer Research (SAKK)

Hypothesis

Do initial prognostic factors predict quality of life during chemotherapy in patients with small-cell lung cancer?

Conclusion

Initial tumour stage, performance status, and previous weight loss can predict quality of life during chemotherapy.

Supporting Evidence

  • Patients with poor prognostic factors reported worse quality of life.
  • Older patients reported worse fatigue and malaise.
  • Patients with extensive disease reported worse general and emotional well-being.
  • Patients with greater weight loss reported worse fatigue and malaise.

Takeaway

Doctors can tell how well a lung cancer patient might feel during treatment by looking at their health before starting chemotherapy.

Methodology

A multicentre, randomised, phase III trial comparing early and late alternating chemotherapy in patients with small-cell lung cancer.

Potential Biases

Attrition bias due to increasing drop-out rates over time.

Limitations

Missing data and small sample sizes may limit the findings.

Participant Demographics

Patients included both males and females, with varying ages and performance statuses.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication